Navigation Links
Aerotel to Showcase High Resolution ECG Monitors at Medica 2013
Date:11/5/2013

DUSSELDORF, Germany, November 5, 2013 /PRNewswire/ --

Aerotel will present two new models for professional and personal use of the world's most advanced mini sized handheld ECG event recorder-transmitters enabling the transmission of ECG data from any place at any time.

Aerotel Medical Systems, a leading global supplier of advanced remote monitoring solutions for telehealth and telecare, will present two new models of the world's smallest and most accurate hand-held ECG monitors at Medica 2013.

The new devices, as well as other innovative products developed by Aerotel, will be presented in Hall 9, Stand C01 at Medica, which will take place on November 20-23, 2013 in Dusseldorf, Germany.

Aerotel will display for the first time the HeartView™ 12L, a high-resolution 12-lead ECG recorder and transmitter for professional use. The HeartView 12L is one of the world's smallest and most powerful ECG monitors.

Aerotel will also present the new HeartView™ P12/8i, an ECG event recorder-transmitter for personal use. The HeartView P12/8i is a powerful ECG device with high-resolution 12-Lead ECG recording technology, which is specifically designed for easy patient use.

Both devices enable the transmission of comprehensive ECG data from any place, at any time. The recorded ECG is transmitted automatically via Bluetooth to Aerotel's Mobile CliniQ App. The ECG data is automatically sent from the mobile device to a cardiac call center for immediate diagnosis.

The HeartView devices allow:

  • Diagnosis of cardiac symptoms
  • Remote monitoring of chronic heart patients
  • Recording and transmission of an ECG to a cardiac call center
  • Cardiac analysis for clinical studies

"Medica 2013 is an excellent opportunity for Aerotel to present the most advanced ECG mobile solutions currently available on the market," said Aerotel's president and CEO David Rubin. "The two new mobile devices are aimed at improving the patients' quality of life, enabling people who previously had to remain in the hospital, to go on with their normal life."

Rubin added that the HeartView devices have already drawn much attention and that Aerotel has already received first orders as well as performed sales.

About Aerotel Medical Systems

Aerotel Medical Systems is a world-leading provider of cost-effective, high quality and user-friendly medical diagnostic systems and devices for home care, eHealth and telemedicine, as well as telecare and personal safety.

For further information, please visit http://www.aerotel.com.

Company Contact:
David Rubin
President & CEO
Aerotel Medical Systems
Tel: +972-35593222 Ext. 100
E-mail: info@aerotel.com 


'/>"/>
SOURCE Aerotel Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun to Showcase Its Safety-Engineered IV Therapy Portfolio at INS
2. ISSYS Inc. will showcase its Titan Wireless Implantable Hemodynamic Monitor and its clinical study summary at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference (Booth 1638) in San Francisco (October 29 to 31, 2013)
3. CPhI Pharma Awards Showcase Industry Drivers
4. PTC Therapeutics to Showcase Breadth of Pipeline at Upcoming R&D Day
5. Olive Medical to Showcase 1080p HD All-In-One Visualization System for ENT Procedures at AAO-HNSF Annual Meeting
6. Philips Showcases Innovations in Radiation Oncology Imaging Technology and Workflow Planning at the 55th American Society for Radiation Oncology (ASTRO) Annual Meeting
7. Accuray to Showcase Clinical Utilization and Adoption of its Latest Advanced Product Platforms at ASTRO 2013
8. Varian and Siemens to Showcase Collaborative Offerings at 2013 ASTRO Meeting in Atlanta
9. B. Braun to Showcase Its Safety-Engineered IV Therapy Portfolio at AVA
10. Novation Innovative Technology Expo To Showcase Products that Improve Patient Outcomes, Increase Safety
11. Medical Supplies Specialist Med Supply Shop Showcases Its New Range of Incontinence Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... , ... Journal of Oral Implantology – Tooth loss is not ... health, including complications with speech, eating, and overcompensation of mouth due to the deficiency. ... As the number of tooth replacements increase, it is imperative to design an implant ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete ... has been honored by Enterprising Women magazine as one of its 2017 Enterprising ... women business owners. Winners have demonstrated that they have fast-growth businesses, mentor or ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... RawTrition now ... easy way to get nutrients from SUPERFOODS! , RawTrition is taking nutrients ... the cellular level because the body recognizes its raw form (unlike the synthetically made ...
(Date:4/26/2017)... ... 26, 2017 , ... MYOLYN, a medical technology company dedicated ... received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two ... devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, ... cells) Phase I/II HOPE clinical trial in Duchenne announced today. , Coalition ...
Breaking Medicine News(10 mins):